Pfizer's API business revenue falls 13% on lower international sales

By Gareth Macdonald

- Last updated on GMT

iStock/Carther
iStock/Carther

Related tags Revenue Pfizer

Revenue generated by Pfizer’s API and contracting business fell in the second quarter.

The US drug firm’s contract manufacturing business – Pfizer CentreOne - generated $171m (€144m) in the three months to the end of June, down 13% on the year earlier quarter.

In the US, CentreOne – which is a unit of Pfizer’s Essential Health division - generated revenue of $132m, which is up $1m from the contribution in Q2 last year. In contrast, in international markets, the unit brought in $39m, down 39%.

The decline continues the trend seen in Q1 when the CentreOne unit’s revenue fell 8% to $182m as a result of lower international sales.

Pfizer’s total revenue for the second quarter was down 2% at $12.9bn.

Related news

Show more

Related products

show more

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

Indena | 25-Oct-2022 | Technical / White Paper

Indena is well known in the space of naturally derived molecules, with a know-how developed over its one hundred year history. At the same time, the company...

Related suppliers

Follow us

Products

View more

Webinars